Search
Garenoxacin
go.drugbank.com/drugs/DB06160ExperimentalGarenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative bacterial infections.
Nemtabrutinib
go.drugbank.com/drugs/DB18866InvestigationalNemtabrutinib is under investigation in clinical trial NCT05624554 (A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/small Lymphocytic
IMCY-0141
go.drugbank.com/drugs/DB17019InvestigationalIMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin
Red blood cell-encapsulated L-asparaginase
go.drugbank.com/drugs/DB17477InvestigationalIt is being investigated in cancers.[L44923]
Synonyms: asparaginase encapsulated in erythrocytes, L-asparaginase encapsulated in red blood cellsAfizagabar
go.drugbank.com/drugs/DB21439InvestigationalAfizagabar is under investigation in clinical trial NCT02877615 (Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event).
Neutramycin
go.drugbank.com/drugs/DB20809ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Neutramycin is a antibiotic, produced by Streptomyces strain. Neutramycin has a monoisotopic molecular weight of 686.35 Da.
Branosotine
go.drugbank.com/drugs/DB21674ExperimentalThe usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist. Branosotine has a monoisotopic molecular weight of 471.22 Da.
Eltenac
go.drugbank.com/drugs/DB20457ExperimentalThe usage of the INN stem '-ac' in the name indicates that Eltenac is a anti-inflammatory agent, ibufenac derivative. Eltenac has a monoisotopic molecular weight of 300.97 Da.